Results for tag: "Symdeko"

Symdeko is a brand of respiratory drugs used to treat cystic fibrosis (CF). It is a combination of two drugs, tezacaftor and ivacaftor, which work together to improve the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The CFTR protein helps regulate the movement of salt and water in and out of cells, which is important for maintaining healthy lung function. Symdeko is the first and only combination therapy approved by the US Food and Drug Administration (FDA) for the treatment of CF in people aged 12 and older. It is also approved in the European Union and other countries. The Symdeko market is composed of a variety of companies that produce and distribute the drug. These include Vertex Pharmaceuticals, which developed the drug, as well as other pharmaceutical companies such as Mylan, Sandoz, and Hikma. Additionally, there are companies that specialize in the distribution of the drug, such as McKesson and AmerisourceBergen. Show Less Read more